| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/06/2026 | ±2.3% | -0.4% | over-priced |
| 05/06/2026 | ±2.2% | +2.4% | under-priced |
| 11/05/2025 | ±2.0% | +1.3% | over-priced |
| 08/06/2025 | ±2.0% | +1.0% | over-priced |
| 05/07/2025 | ±2.1% | +0.6% | over-priced |
| 08/06/2024 | ±2.7% | +1.2% | over-priced |
| 05/07/2024 | ±1.6% | +0.8% | over-priced |
| 11/06/2023 | ±2.4% | -0.7% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $12.19 | $7.1B | $2.0B |
| Q1 FY2026 | $14.06 | $6.7B | $2.3B |
| Q4 FY2025 | $7.10 | $7.0B | $1.2B |
| Q3 FY2025 | $8.43 | $6.5B | $1.5B |
Blackrock, Inc. (BLK) reports in 79 days, with the next report estimated for 11/28/2026. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced BLK's earnings risk. Fundamentals into the print: EPS up 19.6% year-over-year, revenue up 30.6%. QuantLogix's live 5-factor engine currently reads BLK as a buy at 60/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →